These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 36114601)

  • 41. The efficacy of narrowband UVB treatment in pediatric vitiligo: a retrospective analysis of 26 cases.
    Yazici S; Günay B; Başkan EB; Aydoğan K; Saricaoğlu H; Tunali Ş
    Turk J Med Sci; 2017 Apr; 47(2):381-384. PubMed ID: 28425237
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of Childhood Vitiligo Using Tacrolimus Ointment with Narrowband Ultraviolet B Phototherapy.
    Dayal S; Sahu P; Gupta N
    Pediatr Dermatol; 2016 Nov; 33(6):646-651. PubMed ID: 27699846
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combination of fractional carbon dioxide laser with narrow band ultraviolet B to induce repigmentation in stable vitiligo: A comparative study.
    Doghaim NN; Gheida SF; El-Tatawy RA; Mohammed Ali DA
    J Cosmet Dermatol; 2019 Feb; 18(1):142-149. PubMed ID: 29707867
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The use of Janus kinase inhibitors and narrowband ultraviolet B combination therapy in non-segmental vitiligo.
    Yousefian F; Yadlapati S; Browning JC
    J Cosmet Dermatol; 2023 Mar; 22(3):1105-1107. PubMed ID: 36440703
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combined therapy for resistant vitiligo lesions: NB-UVB, microneedling, and topical latanoprost, showed no enhanced efficacy compared to topical latanoprost and NB-UVB.
    Stanimirovic A; Kovacevic M; Korobko I; Šitum M; Lotti T
    Dermatol Ther; 2016 Sep; 29(5):312-316. PubMed ID: 27356486
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Study the effect of erbium:YAG laser plus topical 5-flurouracil in stable vitiligo resistant to NB-UVB phototherapy.
    Doghaim NN; El-Tatawy RA; Ismail MA; Ali DAM; El Attar YA
    J Cosmet Dermatol; 2020 Jan; 19(1):122-130. PubMed ID: 31571367
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combination of narrow band UVB and topical calcipotriol for the treatment of vitiligo.
    Goktas EO; Aydin F; Senturk N; Canturk MT; Turanli AY
    J Eur Acad Dermatol Venereol; 2006 May; 20(5):553-7. PubMed ID: 16684283
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Beneficial UVB phototherapy preceding a fractional CO
    Helou J; Soutou B; Maatouk I; Merhy R; Assaf J; Sarkis AS; Jabbour R; Kaikati J; Tomb R
    J Cosmet Dermatol; 2022 Dec; 21(12):6783-6787. PubMed ID: 36121343
    [TBL] [Abstract][Full Text] [Related]  

  • 49. DEFB1 gene polymorphisms modify vitiligo extent and response to NB-UVB phototherapy.
    Salem RM; Abdelrahman AMN; Abd El-Kareem HM; Seif M
    Dermatol Ther; 2021 May; 34(3):e14921. PubMed ID: 33647170
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Topical calcipotriene and narrowband ultraviolet B in the treatment of vitiligo.
    Kullavanijaya P; Lim HW
    Photodermatol Photoimmunol Photomed; 2004 Oct; 20(5):248-51. PubMed ID: 15379875
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Home vs hospital narrowband UVB treatment by a hand-held unit for new-onset vitiligo: A pilot randomized controlled study.
    Liu B; Sun Y; Song J; Wu Z
    Photodermatol Photoimmunol Photomed; 2020 Jan; 36(1):14-20. PubMed ID: 31206787
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy, predictors of response, and long-term follow-up in patients with vitiligo treated with narrowband UVB phototherapy.
    Nicolaidou E; Antoniou C; Stratigos AJ; Stefanaki C; Katsambas AD
    J Am Acad Dermatol; 2007 Feb; 56(2):274-8. PubMed ID: 17224369
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of using oral methotrexate with phototherapy in the treatment of vitiligo in comparison with single phototherapy treatment: A double-blinded randomized controlled trial.
    Lajevardi V; Hosseini ZSS; Heidari S
    Photodermatol Photoimmunol Photomed; 2023 Nov; 39(6):657-662. PubMed ID: 37859524
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial.
    Dell'Anna ML; Mastrofrancesco A; Sala R; Venturini M; Ottaviani M; Vidolin AP; Leone G; Calzavara PG; Westerhof W; Picardo M
    Clin Exp Dermatol; 2007 Nov; 32(6):631-6. PubMed ID: 17953631
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of efficacy of narrow band UVB therapies with UVB alone, in combination with calcipotriol, and with betamethasone and calcipotriol in vitiligo.
    Akdeniz N; Yavuz IH; Gunes Bilgili S; Ozaydın Yavuz G; Calka O
    J Dermatolog Treat; 2014 Jun; 25(3):196-9. PubMed ID: 23441902
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure.
    Liu LY; Strassner JP; Refat MA; Harris JE; King BA
    J Am Acad Dermatol; 2017 Oct; 77(4):675-682.e1. PubMed ID: 28823882
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of a preceding laser dermabrasion on the outcome of combined therapy with narrowband ultraviolet B and potent topical steroids for treating nonsegmental vitiligo in resistant localizations.
    Bayoumi W; Fontas E; Sillard L; Le Duff F; Ortonne JP; Bahadoran P; Lacour JP; Passeron T
    Br J Dermatol; 2012 Jan; 166(1):208-11. PubMed ID: 21824124
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A randomized, double-blinded, placebo-controlled trial of pseudocatalase cream and narrowband ultraviolet B in the treatment of vitiligo.
    Bakis-Petsoglou S; Le Guay JL; Wittal R
    Br J Dermatol; 2009 Oct; 161(4):910-7. PubMed ID: 19523170
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Narrowband Ultraviolet B Combined with Topical Simvastatin Solution in the Treatment of Vitiligo: A Case Report.
    Hu W; Ma Y; Lin F; Zhou M; Xu AE
    Photobiomodul Photomed Laser Surg; 2022 May; 40(5):362-364. PubMed ID: 35559713
    [No Abstract]   [Full Text] [Related]  

  • 60. Evaluation of combination use of phenytoin cream 1% and fractional CO
    Abasifar H; Ghalamkarpour F; Diab R; Abdollahimajd F
    Dermatol Ther; 2022 Aug; 35(8):e15635. PubMed ID: 35699662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.